BLCO
Bausch + Lomb Corp
NYSE: BLCO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$16.18
+1.70% today
Updated 2026-05-08
Market cap
$5.67B
P/E ratio
—
P/S ratio
1.11x
EPS (TTM)
$-0.62
Dividend yield
—
52W range
$11 – $19
Volume
0.4M
WallStSmart proprietary scores
47
out of 100
Grade: C
Sell
Investment rating
5.3
Growth
C+4.5
Quality
C3.5
Profitability
D7.7
Valuation
B+2/9
Piotroski F-Score
Weak
0.9
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →195 stocks currently score above 75
Price targets
Analyst target
$18.04
+11.50%
12-Month target
—
—
Intrinsic (DCF)
$40.13
Margin of safety
+57.56%
1 Strong Buy3 Buy9 Hold0 Sell1 Strong Sell
Price chart
Stock snapshot
Strengths
+ 57.56% below intrinsic value
Risks
- Piotroski 2/9 — weak financial health
- Altman Z 0.93 — distress zone
- Thin margins at -7.06%
- Negative free cash flow $-68.00M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $3.77B | $4.15B | $4.79B | $5.10B | $5.10B |
| Net income | $6.00M | $-260.00M | $-317.00M | $-360.00M | $-71.00M |
| EPS | — | — | — | — | $-0.62 |
| Free cash flow | $170.00M | $-198.00M | $-59.00M | $-66.00M | $-68.00M |
| Profit margin | 0.16% | -6.27% | -6.62% | -7.06% | -7.06% |
Peer comparison
Smart narrative
Bausch + Lomb Corp trades at $16.18. Our Smart Value Score of 47/100 indicates the stock is fair. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 0.93, it sits in the distress. TTM revenue stands at $5.10B. with profit margins at -7.06%. Our DCF model estimates intrinsic value at $40.13.
Frequently asked questions
What is Bausch + Lomb Corp's stock price?
Bausch + Lomb Corp (BLCO) trades at $16.18.
Is Bausch + Lomb Corp overvalued?
Smart Value Score 47/100 (Grade C, Sell). DCF value $40.13.
What is the price target of Bausch + Lomb Corp (BLCO)?
The analyst target price is $18.04, representing +11.5% upside from the current price of $16.18.
What is the intrinsic value of Bausch + Lomb Corp (BLCO)?
Based on our DCF model, intrinsic value is $40.13, a +57.6% margin of safety versus $16.18.
What is Bausch + Lomb Corp's revenue?
TTM revenue is $5.10B.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
0.93 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio1.11x
ROE-5.39%
Beta0.59
50D MA$16.48
200D MA$15.94
Shares out0.36B
Float0.04B
Short ratio—
Avg volume0.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—